Form 4: Standard BioTools CEO Michael Egholm Reports Stock Transactions
SEC Form 4 Filing
Michael Egholm, President & CEO of Standard BioTools Inc., reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On April 4, 2025, Michael Egholm, the President & CEO of Standard BioTools Inc., engaged in transactions involving the company's common stock and restricted stock units (RSUs).
- Egholm acquired 196,512 shares of common stock through the vesting of RSUs.
- Simultaneously, 57,676 shares were withheld to satisfy tax obligations related to the vesting of these RSUs at a price of $1.07 per share.
- Following these transactions, Egholm directly owns 2,774,842 shares of Standard BioTools Inc.
- He also holds 196,513 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives receiving stock-based compensation. It provides transparency into the executive's holdings and transactions in the company's stock.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives.
- The vesting schedule of the RSUs (four equal annual installments) is a common vesting structure.
- Tax withholding upon RSU vesting is also a standard procedure.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the number of outstanding shares.
- The tax withholding benefits the government.
Key Dates
| Date | Description |
|---|---|
| 04/04/2022 | Date of original RSU grant to the Reporting Person. |
| 04/06/2022 | Date Form 4 was filed with the SEC reporting the original RSU grant. |
| 04/04/2023 | First vesting date of the RSUs, vesting in four equal annual installments. |
| 04/04/2025 | Date of the reported transactions: RSU vesting and tax withholding. |
| 04/08/2025 | Date of signature for the Form 4 filing. |
Keywords
Standard BioTools Inc., Michael Egholm, Form 4, Restricted Stock Units, RSUs, Stock Transactions, Beneficial Ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.